阿米洛里德:对抗性高血压的旧药物进行重新检查
1Division of Cardiology, Severance Cardiovascular Hospital, Integrative Research Center for Cerebrovascular and Cardiovascular Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.
Clinical hypertension
|December 9, 2025
概括
阿米洛里德为耐药性高血压提供了与螺旋龙相比耐受性更好的替代品,显示了相似的血压降低和更少的副作用. 这种节的利尿剂对某些患者亚组可能特别有益.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗性高血压 (RH) 是一个重大的临床挑战,通常需要多种药物.
- 螺旋乳是一种常见的第四线治疗方法,但具有显著的不良影响.
- 作为一种替代疗法,提议使用上皮质通道 (ENaC) 抑制剂阿米洛里德.
研究的目的:
- 对抗高血压患者的阿米洛里德与螺旋乳的疗效和安全性进行比较.
- 评估阿米洛里德作为斯皮罗诺拉克的潜在替代品,特别是对于不耐受矿物质皮质类受体对抗剂的患者.
主要方法:
- 对抗高血压的spironolactone与amiloride (SPARE) 试验随机选择了118名RH患者,在12周内接受spironolactone (12-25 mg) 或amiloride (5-10 mg) 的治疗.
- 家庭系统血压 (SBP) 是主要的结局指标.
- 评估了安全概况,包括不良事件和耐受性.
主要成果:
- 斯皮罗诺拉克和阿米洛里德都显示出家庭SBP的显著和可比降低 (-14.7 mmHg与-13.6 mmHg).
- 阿米洛里德 (Amiloride) 显示出良好的安全性,副作用极小,与可引起妇产不适的螺旋乳不同.
- 亚组分析表明,阿米洛里德在患有较高BMI和较低阿尔多-因比率的患者中具有潜在的疗效.
结论:
- 阿米洛里德是一种可行的,耐受性良好的替代品spironolactone管理耐药高血压.
- 阿米洛里德的独特机制,可能涉及血管ENaC抑制,可以在各种氨酸-氨酸水平上提供好处.
- 该SPARE试验提供了重要的证据,支持阿米洛里德在RH治疗中的作用,特别是对于患有与螺旋龙相关的副作用的患者.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
01:30Heart Failure V: Medical Management
200
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
200
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
01:22Heart Failure Drugs: Diuretics
768
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
768